Eosinophilic asthma | Neutrophilic asthma | Mixed granulocytic asthma | Paucigranulocytic asthma | Healthy subjects | p value (Kruskal-Wallis test) | |
---|---|---|---|---|---|---|
Sp. eosinophils ≥3 % | Sp. eosinophils <3 % | Sp. eosinophils ≥3 % | Sp. eosinophils <3 % | |||
Sp. neutrophils <76 % | Sp. neutrophils ≥76 % | Sp. neutrophils ≥76 % | Sp. neutrophils <76 % | |||
Total non-squamous cell count (× 106/g) | 1.18 (0.56–2.85)‡* | 1.84 (0.82–5.52)‡*† | 4.10 (1.07–12.00)‡*† | 0.81 (0.40–2.07) | 0.64 (0.37–1.30) | 0.0001 |
Viability (%) | 64 (50–75) | 79 (68–88)‡*† | 81 (67–86)‡*† | 64 (48–75) | 67 (53–78) | 0.0001 |
Squamous cells (%) | 13 (5–25)‡* | 12 (3–28)‡* | 6 (2–23)‡* | 18 (8–35) | 18 (10–31) | 0.0001 |
Eosinophils | ||||||
x 103/g | 201 (64–636)‡* | 3 (0–27)‡†§ | 271 (46–685)‡* | 3 (0–10)‡ | 0 (0–2) | 0.0001 |
% of non-squamous cells | 17.1 (7.4–38.0)‡* | 0.2 (0.0–1.0)‡†§ | 5.2 (3.4–8.8)‡*† | 0.4 (0.0–1.0)‡ | 0.0 (0.0–0.4) | - |
Neutrophils | ||||||
x 103/g | 335 (135–823)‡ | 1504 (707–4728)‡*† | 3272 (881–10992)‡*† | 270 (90–795) | 210 (63–563) | 0.0001 |
% of non-squamous cells | 33 (16–50)* | 87 (82–93)‡*† | 83 (79–88)‡*† | 42 (21–58) | 36 (13–63) | - |
Macrophages | ||||||
x 103/g | 288 (144–648) | 169 (52–425)‡*† | 218 (77–607) | 337 (167–853) | 285 (120–568) | 0.0001 |
% of non-squamous cells | 27 (16–43)‡* | 9 (4–13)‡*† | 6 (3–9)‡*† | 46 (29–61) | 46 (30–67) | 0.0001 |
Lymphocytes | ||||||
x 103/g | 19 (5–52)‡* | 12 (2–41) | 19 (0–88) | 10 (3–31) | 10 (4–26) | 0.0012 |
% of non-squamous cells | 1.7 (0.6–3.2) | 1.0 (0.3–1.6)‡*† | 0.6 (0.0–1.8)‡† | 1.4 (0.5–2.8) | 1.8 (0.8–3.4) | 0.0001 |
Epithelial cells | ||||||
x 103/g | 56 (20–140)‡ | 18 (3–67)‡*† | 15 (0–106)*† | 50 (23–115)‡ | 35 (12–86) | 0.0001 |
% of non-squamous cells | 5.0 (2.0–8.6)* | 1.0 (0.4–2.0)‡*† | 0.6 (0.2–1.8)‡*† | 6.0 (2.8–13.0) | 4.8 (2.2–11.8) | 0.0001 |